Company Overview: Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nervous system (CNS) to address the root cause of disease. The company is advancing clinical programs for Duchenne muscular dystrophy (DMD) and myotonic dystrophy type 1 (DM1) as well as a preclinical programs for facioscapulohumeral muscular dystrophy (FSHD) and Pompe disease.

At Dyne, we are on a mission to deliver functional improvement for individuals, families and communities. com/ , and follow us on X , LinkedIn and Facebook . Role Summary: The Associate Director, Formulation and Drug Product Development will be accountable for all internal and external activities related to successful formulation development for Dyne’s bioconjugate drug products to ensure favorable manufacturability, product quality, and long-term stability.

This role will partner closely with colleagues in Research, Pharmaceutical Quality, and Manufacturing to define Dyne’s strategy for bringing best-in-class medicines to patients in need, including high-concentration formulations for subcutaneous administration and lyophilized drug products to ensure seamless supply of all drug products for clinical trials. This role is based in Waltham, MA without the possibility of being a remote role. Physical presence onsite is expected on 4-5 days/week.

Responsibilities

Include: Act as the subject matter expert for drug product development within the Technical Development group, including formulation development, selection of container closure systems, and sterile fill finish clinical manufacturing. Act as main point of contact for CDMO(s) for external formulation development activities, and liaise with the Research group to define, streamline and execute early-stage formulation development efforts. Build and enhance internal capabilities for formulation development in the laboratory.

Responsible for development, tech transfer, and scale-up of drug product processes, and cGMP manufacturing of clinical grade drug product (Phase 1-3). Key contributor to drug product sections of early-stage clinical filings (INDs/IMPDs/Health Canada). Collaborate with Technical Development, Manufacturing, Quality Control, Quality Assurance, and Regulatory Affairs to ensure continuity of drug supply for early clinical evaluation.

Responsible for driving execution of the formulation development plan at CDMO (PO through delivery). Champion a strong winning culture, fostering teamwork and commitment to excellence through transparent communication, engagement and collaboration.

Requirements

: PhD or equivalent experience in a scientific discipline and a minimum of 8+ years related experience. Proven experience in clinical drug product formulation development including liquid fill finish, lyophilization, subcutaneous formulations, and other injectables. Expertise in sterile fill-finish early clinical manufacturing as well as understanding of analytical techniques that support manufacturing activities.

Demonstrated understanding of the principles and applications associated with external manufacturing operations from development to clinical manufacturing.

Strategic thinker with a sense of urgency to deliver quality results on time and in a highly ethical and professional manner. Experience managing complex schedules and priorities in a dynamic biotech environment. Ability to work, influence, and gain consensus across multiple functions (Technical Operations, Quality and Regulatory Affairs).

Collaborative work style to be part of a team to identify process gaps and constructively develop solutions. Excellent interpersonal, verbal, and written communication skills with the ability to establish strong cross-functional relationships.